研報掘金丨華鑫證券:中際旭創毛利率逐季度提升,上調至“買入”評級
華鑫證券研報指出,作為主力光模塊供應商,中際旭創上半年歸母淨利潤和扣非淨利潤同比和環比均呈現較快增長。毛利率延續了逐遂季度提升的趨勢,Q2毛利率相較Q1有較大提升,主要得益於800G等高速光模塊的佔比提升、良率提高、設計改進等因素。在AI基礎設施建設、CSP客户較強的資本開支及其ASIC芯片和以太網數據中心催生的400G和800G光模塊需求之下,整體行業保持高景氣度,公司有望持續受益於行業需求增長。公司在光模塊領域具有技術實力和規模化優勢,800G、1.6T高速產品逐步放量有望帶動公司業績進一步增長,上調至“買入”投資評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.